Member of Drug Trafficking Organisation Sentenced for Fentanyl Distribution & Money Laundering

A New Jersey man has been sentenced to 234 months in prison and five years of supervised release for distributing hundreds of kilograms of fentanyl analogues and laundering the proceeds, the US Department of Justice (DOJ) has confirmed.

Thomas Padovano, 52, of Newark, admitted that between approximately January 2014 and September 2020 he and fellow members of a drug trafficking organisation agreed to import and distribute controlled substances and analogues, including fentanyl-related compounds, methylone and ketamine. The conspiracy sourced product from a supplier in China and distributed it across New Jersey, both in bulk and as counterfeit pharmaceutical pills laced with fentanyl analogues. Padovano further admitted conducting financial transactions designed to disguise the origin and beneficial ownership of more than US$300,000 in drug proceeds.

The case is a useful reminder that narcotics trafficking and the laundering that sustains it remain tightly coupled enforcement priorities, with the DOJ's Money Laundering, Narcotics and Forfeiture Section (MNF) explicitly targeting the financial facilitators, gatekeepers and command structures that allow trafficking organisations to monetise their activity. For institutions, the typologies on display here are familiar but enduring: structured cash movement, concealment of beneficial ownership, and the integration of proceeds linked to counterfeit pharmaceutical supply chains. Transactions touching novel psychoactive substances and pill-press precursors continue to warrant heightened scrutiny, particularly where China-based suppliers and cross-border parcel flows feature.

The investigation was led by the Homeland Security Investigations (HSI) Newark Field Division, with support from the Federal Bureau of Investigation (FBI), the Internal Revenue Service Criminal Investigation (IRS-CI), US Customs and Border Protection (CBP) and local agencies.

Read the press release here.